Zoe D. Draelos, MD, from Duke University, notes that clascoterone cream's unique sebum reduction mechanism provides effective, highly tolerable, and core acne treatment. The first episode of the ...

Ascletis Pharma has reported positive topline Phase III results showing that denifanstat (ASC40), a first-in-class oral FASN inhibitor for moderate-to-severe acne, delivered a favorable long-term ...

Sebum is the number one enemy of human skin. That’s what dermatologist Dr. Rachael Eckel of The Skin Health Institute in Trinidad and Medical Advisor for ZO Skin Health believes, since excess sebum is ...

Struggling with acne and pigmentation? Discover expert-recommended tips, skincare habits, and treatments to reduce dark spots ...

HONG KONG, Jan. 29, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announced positive topline results from the Phase III open-label study (NCT06248008) evaluating denifanstat ...

Unlike teenage breakouts, which are mainly driven by hormonal fluctuation, the causes of adult acne are more complex and “still not as well understood”, added Dr Sarah Too, medical director of Astria ...

Learn more about what causes acne in humans and how it can sometimes impact animals, too.

There’s a common misconception that if your skin is acne-prone and/or oily you should skip the moisturising step of your ...

Whether you’re a teenager in the dredges of puberty or well into adulthood, acne is a persistent problem that can plague anyone. Acne surfaces with carrying levels of severity, and depending on the ...